Ferric carboxymaltose in patients with heart failure and iron deficiency. (abre nova janela)

Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators.

Fonte‎: N Engl J Med 2009;361(25):2436-48.

Indexado‎: PubMed 19920054

DOI‎: 10.1056/NEJMoa0908355

https://www.ncbi.nlm.nih.gov/pubmed/19920054 (abre nova janela)

Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (abre nova janela)

Bayam L, Tait WF, Macartney ID.

Fonte‎: Vasc Endovascular Surg 2007;41(5):460-2.

Indexado‎: PubMed 17942864

DOI‎: 10.1177/1538574407303172

https://www.ncbi.nlm.nih.gov/pubmed/17942864 (abre nova janela)

Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (abre nova janela)

Binder RK, Barbanti M, Ye J, Toggweiler S, Tan J, Freeman M, Cheung A, Wood DA, Webb JG.

Fonte‎: Catheter Cardiovasc Interv 2014;83(6):E221-6.

Indexado‎: PubMed 24402965

DOI‎: 10.1002/ccd.25389

https://www.ncbi.nlm.nih.gov/pubmed/24402965 (abre nova janela)

Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (abre nova janela)

Cho BC, Serini J, Zorrilla-Vaca A, Scott MJ, Gehrie EA, Frank SM, Grant MC

Fonte‎: Anesth Analg 2019;128(5):981-92.

Indexado‎: PubMed 30649068

DOI‎: 10.1213/ANE.0000000000004005

https://www.ncbi.nlm.nih.gov/pubmed/30649068 (abre nova janela)

Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (abre nova janela)

Chua D, Amadio A, San C.

Fonte‎: Can J Cardiol 2014;30(Suppl):S234.

DOI‎: 10.1016/j.cjca.2014.07.398

http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (abre nova janela)

Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (abre nova janela)

Cladellas M, Farré N, Comín-Colet J, Gómez M, Meroño O, Bosch MA, Vila J, Molera R, Segovia A, Bruguera J.

Fonte‎: Am J Cardiol 2012;110(7):1021-6.

Indexado‎: PubMed 22771376

DOI‎: 10.1016/j.amjcard.2012.05.036

https://www.ncbi.nlm.nih.gov/pubmed/22771376 (abre nova janela)

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (abre nova janela)

Filippatos G, Farmakis D, Colet JC, Dickstein K, Lüscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart Rothe B, Greenlaw N, Ford I, Ponikowski P, Anker SD.

Fonte‎: Eur J Heart Fail 2013;15(11):1267-76.

Indexado‎: PubMed 23787722

DOI‎: 10.1093/eurjhf/hft099

https://www.ncbi.nlm.nih.gov/pubmed/23787722 (abre nova janela)

Current status of pharmacologic therapies in patient blood management. (abre nova janela)

Goodnough LT, Shander A.

Fonte‎: Anesth Analg 2013;116(1):15-34.

Indexado‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 (abre nova janela)

Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (abre nova janela)

Hogervorst EK, Rosseel PM, van de Watering LM, Brand A, Bentala M, van der Bom JG, van der Meer NJ.

Fonte‎: J Cardiothorac Vasc Anesth 2016;30(2):363-72.

Indexado‎: PubMed 26809765

DOI‎: 10.1053/j.jvca.2015.10.021

https://www.ncbi.nlm.nih.gov/pubmed/26809765 (abre nova janela)

The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (abre nova janela)

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, van Rensburg A, Beattie WS.

Fonte‎: Transfusion 2008;48(4):666-72.

Indexado‎: PubMed 18194382

DOI‎: 10.1111/j.1537-2995.2007.01590.x

https://www.ncbi.nlm.nih.gov/pubmed/18194382 (abre nova janela)

Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (abre nova janela)

Kong R, Hutchinson N, Hill A, Ingoldby F, Skipper N, Jones C, Bremner S, Bruce C, Wright J, Lewis M, Newman S, Chevassut T, Hildick-Smith D

Fonte‎: Br J Anaesth. 2022;128(5):796-805.

Indexado‎: PubMed 35256150

DOI‎: 10.1016/j.bja.2022.01.034

https://pubmed.ncbi.nlm.nih.gov/35256150/ (abre nova janela)

Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (abre nova janela)

Lin DM, Lin ES, Tran MH.

Fonte‎: Transfus Med Rev 2013;27(4):221-34.

Indexado‎: PubMed 24135037

DOI‎: 10.1016/j.tmrv.2013.09.001

https://www.ncbi.nlm.nih.gov/pubmed/24135037 (abre nova janela)

The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (abre nova janela)

Loor G, Rajeswaran J, Li L, Sabik JF 3rd, Blackstone EH, McCrae KR, Koch CG.

Fonte‎: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.

Indexado‎: PubMed 23998782

DOI‎: 10.1016/j.jtcvs.2013.06.033

https://www.ncbi.nlm.nih.gov/pubmed/23998782 (abre nova janela)

Jehovah's Witnesses and cardiac surgery: a single institution's experience. (abre nova janela)

McCartney S, Guinn N, Roberson R, Broomer B, White W, Hill S.

Fonte‎: Transfusion 2014;54(10 Pt 2):2745-52.

Indexado‎: PubMed 24809815

DOI‎: 10.1111/trf.12696

https://www.ncbi.nlm.nih.gov/pubmed/24809815 (abre nova janela)

Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (abre nova janela)

Peel JK, Trudeau J, Tano R, Jadunandan S, Callum J, Moussa F, Lin Y

Fonte‎: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.

Indexado‎: PubMed 33483268

DOI‎: 10.1053/j.jvca.2020.12.044

https://pubmed.ncbi.nlm.nih.gov/33483268/ (abre nova janela)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (abre nova janela)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Fonte‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indexado‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (abre nova janela)

Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (abre nova janela)

Rössler J, Hegemann I, Schoenrath F, Seifert B, Kaserer A, Spahn GH, Falk V, Spahn DR

Fonte‎: Anaesthesia 2020;75(8):1039-49.

Indexado‎: PubMed 32342498

DOI‎: 10.1111/anae.15062

https://www.ncbi.nlm.nih.gov/pubmed/32342498 (abre nova janela)

Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (abre nova janela)

Sarac TP, Clifford C, Waters J, Clair DG, Ouriel K.

Fonte‎: J Vasc Surg 2003;37(2):453-5.

Indexado‎: PubMed 12563221

DOI‎: 10.1067/mva.2003.73

https://www.ncbi.nlm.nih.gov/pubmed/12563221 (abre nova janela)

Intravenous iron in heart failure: beyond targeting anemia. (abre nova janela)

Silverberg DS, Iaina A, Schwartz D, Wexler D.

Fonte‎: Curr Heart Fail Rep 2011;8(1):14-21.

Indexado‎: PubMed 21057903

DOI‎: 10.1007/s11897-010-0034-4

https://www.ncbi.nlm.nih.gov/pubmed/21057903 (abre nova janela)

Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (abre nova janela)

Tanaka A, Ota T, Uriel N, Asfaw Z, Onsager D, Lonchyna VA, Jeevanandam V.

Fonte‎: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.

Indexado‎: PubMed 26211405

DOI‎: 10.1016/j.jtcvs.2015.06.059

https://www.ncbi.nlm.nih.gov/pubmed/26211405 (abre nova janela)

Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (abre nova janela)

Usmanov RI, Zueva EB, Silverberg DS, Shaked M.

Fonte‎: J Nephrol 2008;21(2):236-42.

Indexado‎: PubMed 18446719

https://www.ncbi.nlm.nih.gov/pubmed/18446719 (abre nova janela)

Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (abre nova janela)

Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, De Paulis R.

Fonte‎: J Thorac Cardiovasc Surg 2010;139(3):621-7.

Indexado‎: PubMed 20042202

DOI‎: 10.1016/j.jtcvs.2009.10.012

https://www.ncbi.nlm.nih.gov/pubmed/20042202 (abre nova janela)

A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (abre nova janela)

Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L.

Fonte‎: Transfusion 2015;55(7):1644-54.

Indexado‎: PubMed 25702777

DOI‎: 10.1111/trf.13027

https://www.ncbi.nlm.nih.gov/pubmed/25702777 (abre nova janela)

Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (abre nova janela)

Yaffee DW, DeAnda A, Ngai JY, Ursomanno PA, Rabinovich AE, Ward AF, Galloway AC, Grossi EA.

Fonte‎: J Cardiothorac Vasc Anesth 2015;29(3):703-9.

Indexado‎: PubMed 25847415

DOI‎: 10.1053/j.jvca.2014.10.022

https://www.ncbi.nlm.nih.gov/pubmed/25847415 (abre nova janela)

Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (abre nova janela)

Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL.

Fonte‎: Anesthesiology 2011;115(5):929-37.

Indexado‎: PubMed 22027622

DOI‎: 10.1097/ALN.0b013e318232004b

https://www.ncbi.nlm.nih.gov/pubmed/22027622 (abre nova janela)